|
ALG10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.82500048196266E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.84960000438173E-08 |
| Normal-vs-Stage2 |
1.53669999999329E-05 |
| Normal-vs-Stage3 |
7.86169995770081E-09 |
| Normal-vs-Stage4 |
8.19859957701397E-10 |
| Stage1-vs-Stage2 |
5.926000E-01 |
| Stage1-vs-Stage3 |
1.657010E-01 |
| Stage1-vs-Stage4 |
1.785650E-02 |
| Stage2-vs-Stage3 |
6.591800E-01 |
| Stage2-vs-Stage4 |
2.313200E-01 |
| Stage3-vs-Stage4 |
3.734200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.56750001656781E-09 |
| Normal-vs-AfricanAmerican |
1.340450E-03 |
| Normal-vs-Asian |
1.95820000004066E-06 |
| Caucasian-vs-AfricanAmerican |
5.986800E-01 |
| Caucasian-vs-Asian |
8.878800E-01 |
| AfricanAmerican-vs-Asian |
6.587400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.3179682879545E-14 |
| Normal-vs-Female |
1.1072999994699E-07 |
| Male-vs-Female |
3.767600E-04 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.28079999956499E-07 |
| Normal-vs-Age(41-60Yrs) |
3.43149997306114E-09 |
| Normal-vs-Age(61-80Yrs) |
7.73660002728604E-09 |
| Normal-vs-Age(81-100Yrs) |
3.761900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.302000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.112560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.365000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.314000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.048000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.908600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.975800E-02 |
| Classical-VS-Follicular |
4.177700E-03 |
| Classical-VS-Other |
8.506400E-02 |
| Classical-VS-Normal |
2.23100000029675E-07 |
| Tall-VS-Follicular |
7.706800E-01 |
| Tall-VS-Other |
2.724400E-01 |
| Tall-VS-Normal |
4.44790000386774E-08 |
| Follicular-VS-Other |
4.893400E-01 |
| Follicular-VS-Normal |
2.63300004021971E-09 |
| Other-VS-Normal |
3.847300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.69969996252928E-09 |
| Normal-vs-N1 |
7.14860004524809E-09 |
| N0-vs-N1 |
1.979170E-01 |
|
|
